Will IO Biotech (NASDAQ:IOBT) Spend Its Cash Wisely? [Yahoo! Finance]
IO Biotech to Present at Jefferies Global Healthcare Conference
IO Biotech, Inc. (NASDAQ: IOBT) had its price target raised by analysts at HC Wainwright from $8.00 to $12.00. They now have a "buy" rating on the stock.
IO Biotech Reports First Quarter 2024 Financial Results and Provides Business Highlights
IO Biotech Announces Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting